Abstract

When Atlantis launched in July for the final mission of the U.S. Space Shuttle program, it carried microbial experiments probing bacterial biofilms, the genetic makeup of yeast, microgravity effects in a plant-bacterial model system, and a candidate live-attenuated vaccine for combating Streptococcus pneumoniae infections. Other experiments in biology aboard STS-135 looked at the effects of tissue regeneration and wound-healing, the effectiveness of experimental drug therapies against bone loss resulting from microgravity, and how spaceflight affects sleep patterns.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.